Provides significant, new possible commercialization and innovation leadership opportunities for Fire & Flower’s proprietary Hifyre™ digital platform. Couche-Tard shares Fire & Flower’s committment to innovation and the parties intend to explore additional ways to grow and expand Hifyre’s™ capabilities and commercialization opportunities.
• Provides access to Couche-Tard’s leadership team. As a recognized leader in profitable, large-scale, global retail, increasing representation by Couche-Tard’s leadership team on the board of directors of Fire & Flower (the “Board”) is expected to provide significant benefits as the Company scales its operations.
• Delivers potential upside opportunities for Fire & Flower shareholders. The strategic investment, access to Couche-Tard’s leadership and retail infrastructure, combined with their complimentary international scale and experience are expected to better position Fire & Flower for growth and value creation with benefits to all of the Company’s stakeholders, including its shareholders, employees and partners.
https://thecannabisstock.com/2019/07/24/couche-tard-invested-in-flower-and-fire-next-to-hexo-and-aphria/
It's always good to reread some news releases, a big part of CT' interest is the application and possibilities Hifyre’s™ will bring to their core business as well